Literature DB >> 33573223

Impact of Maternal Food Restriction on Heart Proteome in Appropriately Grown and Growth-Restricted Wistar-Rat Offspring.

Andreas Zouridis1, Antigoni Manousopoulou2, Anastasios Potiris1, Polyxeni-Maria Sarli1, Leon Aravantinos1, Panagiota Pervanidou3, Efthymios Deligeoroglou1, Spiros D Garbis4, Makarios Eleftheriades1.   

Abstract

OBJECTIVE: Fetal growth restriction is associated with increased postnatal cardiovascular morbidity. The alterations in heart physiology and structure caused by in utero nutrient deprivation have not been extensively studied. We aim to investigate the impact of maternal food restriction on the cardiac proteome of newborn rats with normal (non-fetal growth-restricted (FGR)) and reduced (FGR) birth weight.
METHODS: On day 14 of gestation, 10 timed pregnant rats were randomized into two nutritional groups: (a) Standard laboratory diet and (b) 50% global food restriction. Pups born to food-restricted mothers were subdivided, based on birthweight, into fetal growth-restricted (FGR) and non-FGR, while pups born from normally nourished mothers were considered controls. Rat neonates were euthanized immediately after birth and the hearts of 11 randomly selected male offspring (n = 4 FGR, n = 4 non-FGR, n = 3 control group) were analyzed using quantitative proteomics.
RESULTS: In total, 7422 proteins were quantified (q < 0.05). Of these, 1175 were differentially expressed in FGR and 231 in non-FGR offspring vs. control with 151 common differentially expressed proteins (DEPs) between the two groups. Bioinformatics analysis of DEPs in FGR vs. control showed decreased integrin and apelin cardiac fibroblast signaling, decreased muscle contraction and glycolysis, and over-representation of a protein network related to embryonic development, and cell death and survival.
CONCLUSION: Our study illustrates the distinct proteomic profile of FGR and non-FGR offspring of food-restricted dams underlying the importance of both prenatal adversities and birth weight in cardiac physiology and development.

Entities:  

Keywords:  FGR; IUGR; cardiac; cardiovascular; fetal programming; food restriction; heart

Year:  2021        PMID: 33573223      PMCID: PMC7912475          DOI: 10.3390/nu13020466

Source DB:  PubMed          Journal:  Nutrients        ISSN: 2072-6643            Impact factor:   5.717


  41 in total

1.  The fetal and infant origins of adult disease.

Authors:  D J Barker
Journal:  BMJ       Date:  1990-11-17

Review 2.  Energy metabolic phenotype of the cardiomyocyte during development, differentiation, and postnatal maturation.

Authors:  Gary D Lopaschuk; Jagdip S Jaswal
Journal:  J Cardiovasc Pharmacol       Date:  2010-08       Impact factor: 3.105

3.  Animal models of fetal growth restriction: Considerations for translational medicine.

Authors:  A M Swanson; A L David
Journal:  Placenta       Date:  2015-03-13       Impact factor: 3.481

4.  Growth in utero, blood pressure in childhood and adult life, and mortality from cardiovascular disease.

Authors:  D J Barker; C Osmond; J Golding; D Kuh; M E Wadsworth
Journal:  BMJ       Date:  1989-03-04

5.  Activin-A limits Th17 pathogenicity and autoimmune neuroinflammation via CD39 and CD73 ectonucleotidases and Hif1-α-dependent pathways.

Authors:  Ioannis Morianos; Aikaterini I Trochoutsou; Gina Papadopoulou; Maria Semitekolou; Aggelos Banos; Dimitris Konstantopoulos; Antigoni Manousopoulou; Maria Kapasa; Ping Wei; Brett Lomenick; Elise Belaidi; Themis Kalamatas; Klinta Karageorgiou; Triantafyllos Doskas; Federica Sallusto; Fan Pan; Spiros D Garbis; Francisco J Quintana; Georgina Xanthou
Journal:  Proc Natl Acad Sci U S A       Date:  2020-05-14       Impact factor: 11.205

Review 6.  Effects of Intrauterine Growth Restriction and Female Sex on Future Blood Pressure and Cardiovascular Disease.

Authors:  Gwendolyn K Davis; Ashley D Newsome; Norma B Ojeda; Barbara T Alexander
Journal:  Curr Hypertens Rep       Date:  2017-02       Impact factor: 5.369

7.  Cardiac expression of kinase-deficient 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase inhibits glycolysis, promotes hypertrophy, impairs myocyte function, and reduces insulin sensitivity.

Authors:  Rajakumar V Donthi; Gang Ye; Chaodong Wu; Donald A McClain; Alex J Lange; Paul N Epstein
Journal:  J Biol Chem       Date:  2004-08-25       Impact factor: 5.157

Review 8.  Targeting the apelin pathway as a novel therapeutic approach for cardiovascular diseases.

Authors:  Jiu-Chang Zhong; Zhen-Zhou Zhang; Wang Wang; Shaun M K McKinnie; John C Vederas; Gavin Y Oudit
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2016-11-04       Impact factor: 5.187

9.  ISUOG Practice Guidelines: diagnosis and management of small-for-gestational-age fetus and fetal growth restriction.

Authors:  C C Lees; T Stampalija; A Baschat; F da Silva Costa; E Ferrazzi; F Figueras; K Hecher; J Kingdom; L C Poon; L J Salomon; J Unterscheider
Journal:  Ultrasound Obstet Gynecol       Date:  2020-08       Impact factor: 7.299

10.  The lifelong impact of fetal growth restriction on cardiac development.

Authors:  Emily P Masoumy; Alexandra A Sawyer; Suash Sharma; Jenny A Patel; Paul M K Gordon; Timothy R H Regnault; Brad Matushewski; Neal L Weintraub; Bryan Richardson; Jennifer A Thompson; Brian K Stansfield
Journal:  Pediatr Res       Date:  2018-06-02       Impact factor: 3.756

View more
  2 in total

1.  The Effect of Prenatal Food Restriction on Brain Proteome in Appropriately Grown and Growth Restricted Male Wistar Rats.

Authors:  Anastasios Potiris; Antigoni Manousopoulou; Andreas Zouridis; Polyxeni-Maria Sarli; Panagiota Pervanidou; George Eliades; Despina N Perrea; Efthymios Deligeoroglou; Spiros D Garbis; Makarios Eleftheriades
Journal:  Front Neurosci       Date:  2021-04-14       Impact factor: 4.677

2.  Liver Proteome Profile of Growth Restricted and Appropriately Grown Newborn Wistar Rats Associated With Maternal Undernutrition.

Authors:  Polyxeni-Maria Sarli; Antigoni Manousopoulou; Elias Efthymiou; Andreas Zouridis; Anastasios Potiris; Panagiota Pervanidou; Konstantinos Panoulis; Nikolaos Vlahos; Efthymios Deligeoroglou; Spiros D Garbis; Makarios Eleftheriades
Journal:  Front Endocrinol (Lausanne)       Date:  2021-05-28       Impact factor: 5.555

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.